Correlation of prognostic and predictive indicators in breast cancer patients from the eastern province of Saudi Arabia

References

1. 1.↵
   1. Chen Z,
   2. Xu L,
   3. Shi W,
   4. Zeng F,
   5. Zhuo R,
   6. Hao X, et al.

   Trends of female and male breast cancer incidence at the global, regional, and national levels, 1990-2017. Breast Cancer Res Treat 2020; 180: 481–490.

   OpenUrl
2. 2.↵
   1. Chaudhri E,
   2. Fathi W,
   3. Hussain F,
   4. Hashmi SK.

   The Increasing Trends in Cases of the Most Common Cancers in Saudi Arabia. J Epidemiol Glob Health 2020; 10: 258–262.

   OpenUrl
3. 3.↵
   1. Babiker S,
   2. Nasir O,
   3. Alotaibi SH,
   4. Marzogi A,
   5. Bogari M,
   6. Alghamdi T.

   Prospective breast cancer risk factors prediction in Saudi women. Saudi J Biol Sci 2020; 27: 1624–1631.

   OpenUrl
4. 4.↵
   1. Al-Moghrabi NM.

   BRCA1 promoter methylation in peripheral blood cells and predisposition to breast cancer. J Taibah Univ Med Sci 2017; 12: 189–193.

   OpenUrl
5. 5.↵
   1. Althubiti MA,
   2. Nour Eldein MM.

   Trends in the incidence and mortality of cancer in Saudi Arabia. Saudi Med J 2018; 39: 1259–1262.

   OpenUrl
6. 6.↵
   1. Al Mulhim FA,
   2. Syed A,
   3. Bagatadah WA,
   4. Al Muhanna AF.

   Breast cancer screening programme: experience from Eastern province, Saudi Arabia. East Mediterr Health J 2015; 21: 111–119.

   OpenUrl
7. 7.↵
   1. Tang P,
   2. Tse GM.

   Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 Update. Arch Pathol Lab Med 2016; 140: 806–814.

   OpenUrl
8. 8.↵
   1. Saggu S,
   2. Rehman H,
   3. Abbas ZK,
   4. Ansari AA.

   Recent incidence and descriptive epidemiological survey of breast cancer in Saudi Arabia. Saudi Med J 2015; 36: 1176–1180.

   OpenUrl
9. 9.↵
   1. Alnegheimish NA,
   2. Alshatwi RA,
   3. Alhefdhi RM,
   4. Arafah MM,
   5. AlRikabi AC,
   6. Husain S.

   Molecular subtypes of breast carcinoma in Saudi Arabia. A retrospective study. Saudi Med J 2016; 37: 506–512.

   OpenUrl
10. 10.↵
    1. Alabdulkarim B,
    2. Hassanain M,
    3. Bokhari A,
    4. AlSaif A,
    5. Alkarji H.

    Age distribution and outcomes in patients undergoing breast cancer resection in Saudi Arabia. A single-institute study. Saudi Med J 2018; 39: 464–469.

    OpenUrl
11. 11.↵
    1. Allison KH,
    2. Hammond MEH,
    3. Dowsett M,
    4. McKernin SE,
    5. Carey LA,
    6. Fitzgibbons PL, et al.

    Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update. J Clin Oncol 2020; 38: 1346–1366.

    OpenUrl
12. 12.↵
    1. Wolff AC,
    2. Hammond MEH,
    3. Allison KH,
    4. Harvey BE,
    5. Mangu PB,
    6. Bartlett JMS, et al.

    Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. J Clin Oncol 2018; 36: 2105–2122.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Kataoka A,
    2. Iwamoto T,
    3. Tokunaga E,
    4. Tomotaki A,
    5. Kumamaru H,
    6. Miyata H, et al.

    Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry. Breast Cancer Res Treat 2016; 160: 163–172.

    OpenUrl
14. 14.↵
    1. Elkablawy MA,
    2. Albasri AM,
    3. Mohammed RA,
    4. Hussainy AS,
    5. Nouh MM,
    6. Alhujaily AS.

    Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients. Saudi Med J 2016; 37: 137–141.

    OpenUrl
15. 15.↵
    1. Al Nemer A.

    The performance of Ki-67 labeling index in different specimen categories of invasive ductal carcinoma of the breast using 2 scoring methods. Appl Immunohistochem Mol Morphol 2017; 25: 86–90.

    OpenUrl
16. 16.↵
    1. Al-Thoubaity FK.

    Molecular classification of breast cancer: A retrospective cohort study. Ann Med Surg (Lond) 2020; 49: 44–48.

    OpenUrl